Yongchang Zhang

Also affiliated with Central South University, Sun Yat-sen University, National Medical Products Administration, National Energy Research Center, Hunan Cancer Hospital, Sun Yat-sen University Cancer Center, University of South China

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC”.

Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC

New England Journal of Medicine(2025)10.1056/nejmoa2512071

N/A

0.884DataRank · unranked

44 citations

Lin Wu, Xiangjiao Meng, Yu Yao, Wei Zuo, Wenxiu Yao +29 more

The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations

Lung Cancer(2024)10.1016/j.lungcan.2024.108040

N/A

0DataRank · unranked

10 citations

Dexiang Gao, Alexander Watson, M Sakamoto, Yunan Nie, A.J. Gibson +13 more

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Annals of Oncology(2025)10.1016/j.annonc.2025.09.140

N/A

0DataRank · unranked

8 citations

Y. Xia, Ke Pan, Fangdi Sun, Aaron C. Tan, Xinran Dong +31 more